Dose escalation study of S-222611 in Patients with solid tumours
Research type
Research Study
Full title
Phase I Open-label, Dose Escalation Study of S-222611 in Patients with Solid Tumours
IRAS ID
44125
Contact name
James Spicer
Contact email
Sponsor organisation
Shionogi & Co., Ltd.
Eudract number
2009-017817-31
Research summary
The import did not bring in any data, please check the applicants form to see if they filled in the Research Summary. If so please import the form again. This problem may have been caused by the an application form being imported before the research summary functionality was available. Please phone the helpdesk if you have any questions or require advice.
REC name
London - London Bridge Research Ethics Committee
REC reference
10/H0804/9
Date of REC Opinion
9 Apr 2010
REC opinion
Further Information Favourable Opinion